Jubilee Platinum PLC
22 June 2007
JUBILEE PLATINUM PLC
('Jubilee' or 'the Company')
ISSUE OF SHARES
Application is to be made to the London Stock Exchange and JSE Limited for
2,142,857 new ordinary shares of nominal value £0.01 each in the capital of the
Company ('New Ordinary Shares') to be admitted to trading on AIM and on JSE
Limited. Dealings are expected to commence in the New Ordinary Shares on 28
June, 2007.
The New Ordinary Shares have been allotted to City Natural Resource High Yield
Trust at the conversion price stipulated in the Convertible Loan Note Agreement
as announced by the Company on 27 January 2006.
The New Ordinary Shares rank pari passu in all respects with the existing
ordinary shares of the Company.
Following admission to trading of the New Ordinary Shares, the total number of
ordinary shares in issue will be 85,817,408.
For further information please contact:
Colin Bird Louise Goodeve/Justine Howarth
Jubilee Platinum plc Parkgreen Communications Ltd
Tel: 07768 397 627 Tel +44 20 7851 7480
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.